SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062054
Filing Date
2023-11-09
Accepted
2023-11-09 16:11:13
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pstx-20230930.htm   iXBRL 10-Q 2901937
2 EX-10.1 pstx-ex10_1.htm EX-10.1 47127
3 EX-31.1 pstx-ex31_1.htm EX-31.1 14571
4 EX-31.2 pstx-ex31_2.htm EX-31.2 14569
5 EX-32.1 pstx-ex32_1.htm EX-32.1 9677
6 EX-32.2 pstx-ex32_2.htm EX-32.2 9701
  Complete submission text file 0000950170-23-062054.txt   9667872

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pstx-20230930_pre.xml EX-101.PRE 370418
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pstx-20230930.xsd EX-101.SCH 59970
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pstx-20230930_def.xml EX-101.DEF 221963
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pstx-20230930_cal.xml EX-101.CAL 47912
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pstx-20230930_lab.xml EX-101.LAB 496613
66 EXTRACTED XBRL INSTANCE DOCUMENT pstx-20230930_htm.xml XML 1582098
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39376 | Film No.: 231392508
SIC: 2836 Biological Products, (No Diagnostic Substances)